Report Detail

Pharma & Healthcare Global Mesalazine Market Research Report 2021

  • RnM4286969
  • |
  • 23 February, 2021
  • |
  • Global
  • |
  • 117 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Mesalazine Market Overview

  • 1.1 Product Overview and Scope of Mesalazine
  • 1.2 Mesalazine Segment by Type
    • 1.2.1 Global Mesalazine Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Purity ≥ 97 %
    • 1.2.3 Purity ≥ 98 %
    • 1.2.4 Purity ≥ 99 %
  • 1.3 Mesalazine Segment by Application
    • 1.3.1 Mesalazine Sales Comparison by Application: (2021-2027)
    • 1.3.2 Mesalazine Tablets
    • 1.3.3 Mesalazine Capsules
    • 1.3.4 Others
  • 1.4 Global Mesalazine Market Size Estimates and Forecasts
    • 1.4.1 Global Mesalazine Revenue 2016-2027
    • 1.4.2 Global Mesalazine Sales 2016-2027
    • 1.4.3 Mesalazine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Mesalazine Market Competition by Manufacturers

  • 2.1 Global Mesalazine Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Mesalazine Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Mesalazine Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Mesalazine Manufacturing Sites, Area Served, Product Type
  • 2.5 Mesalazine Market Competitive Situation and Trends
    • 2.5.1 Mesalazine Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Mesalazine Players Market Share by Revenue
    • 2.5.3 Global Mesalazine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Mesalazine Retrospective Market Scenario by Region

  • 3.1 Global Mesalazine Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Mesalazine Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Mesalazine Market Facts & Figures by Country
    • 3.3.1 North America Mesalazine Sales by Country
    • 3.3.2 North America Mesalazine Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Mesalazine Market Facts & Figures by Country
    • 3.4.1 Europe Mesalazine Sales by Country
    • 3.4.2 Europe Mesalazine Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Mesalazine Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Mesalazine Sales by Region
    • 3.5.2 Asia Pacific Mesalazine Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Mesalazine Market Facts & Figures by Country
    • 3.6.1 Latin America Mesalazine Sales by Country
    • 3.6.2 Latin America Mesalazine Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Mesalazine Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Mesalazine Sales by Country
    • 3.7.2 Middle East and Africa Mesalazine Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 U.A.E

4 Global Mesalazine Historic Market Analysis by Type

  • 4.1 Global Mesalazine Sales Market Share by Type (2016-2021)
  • 4.2 Global Mesalazine Revenue Market Share by Type (2016-2021)
  • 4.3 Global Mesalazine Price by Type (2016-2021)

5 Global Mesalazine Historic Market Analysis by Application

  • 5.1 Global Mesalazine Sales Market Share by Application (2016-2021)
  • 5.2 Global Mesalazine Revenue Market Share by Application (2016-2021)
  • 5.3 Global Mesalazine Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Syntese A/S
    • 6.1.1 Syntese A/S Corporation Information
    • 6.1.2 Syntese A/S Description and Business Overview
    • 6.1.3 Syntese A/S Mesalazine Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Syntese A/S Product Portfolio
    • 6.1.5 Syntese A/S Recent Developments/Updates
  • 6.2 Divis Laboratories
    • 6.2.1 Divis Laboratories Corporation Information
    • 6.2.2 Divis Laboratories Description and Business Overview
    • 6.2.3 Divis Laboratories Mesalazine Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Divis Laboratories Product Portfolio
    • 6.2.5 Divis Laboratories Recent Developments/Updates
  • 6.3 Cambrex Corporation
    • 6.3.1 Cambrex Corporation Corporation Information
    • 6.3.2 Cambrex Corporation Description and Business Overview
    • 6.3.3 Cambrex Corporation Mesalazine Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Cambrex Corporation Product Portfolio
    • 6.3.5 Cambrex Corporation Recent Developments/Updates
  • 6.4 Ipca Laboratories
    • 6.4.1 Ipca Laboratories Corporation Information
    • 6.4.2 Ipca Laboratories Description and Business Overview
    • 6.4.3 Ipca Laboratories Mesalazine Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Ipca Laboratories Product Portfolio
    • 6.4.5 Ipca Laboratories Recent Developments/Updates
  • 6.5 PharmaZell
    • 6.5.1 PharmaZell Corporation Information
    • 6.5.2 PharmaZell Description and Business Overview
    • 6.5.3 PharmaZell Mesalazine Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 PharmaZell Product Portfolio
    • 6.5.5 PharmaZell Recent Developments/Updates
  • 6.6 Lasa Loboratory
    • 6.6.1 Lasa Loboratory Corporation Information
    • 6.6.2 Lasa Loboratory Description and Business Overview
    • 6.6.3 Lasa Loboratory Mesalazine Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Lasa Loboratory Product Portfolio
    • 6.6.5 Lasa Loboratory Recent Developments/Updates
  • 6.7 Erregierre SpA
    • 6.6.1 Erregierre SpA Corporation Information
    • 6.6.2 Erregierre SpA Description and Business Overview
    • 6.6.3 Erregierre SpA Mesalazine Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Erregierre SpA Product Portfolio
    • 6.7.5 Erregierre SpA Recent Developments/Updates
  • 6.8 Corden Pharma Bergamo
    • 6.8.1 Corden Pharma Bergamo Corporation Information
    • 6.8.2 Corden Pharma Bergamo Description and Business Overview
    • 6.8.3 Corden Pharma Bergamo Mesalazine Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Corden Pharma Bergamo Product Portfolio
    • 6.8.5 Corden Pharma Bergamo Recent Developments/Updates
  • 6.9 CTX Lifescience
    • 6.9.1 CTX Lifescience Corporation Information
    • 6.9.2 CTX Lifescience Description and Business Overview
    • 6.9.3 CTX Lifescience Mesalazine Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 CTX Lifescience Product Portfolio
    • 6.9.5 CTX Lifescience Recent Developments/Updates
  • 6.10 Ishita Active Pharma Ingredients
    • 6.10.1 Ishita Active Pharma Ingredients Corporation Information
    • 6.10.2 Ishita Active Pharma Ingredients Description and Business Overview
    • 6.10.3 Ishita Active Pharma Ingredients Mesalazine Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Ishita Active Pharma Ingredients Product Portfolio
    • 6.10.5 Ishita Active Pharma Ingredients Recent Developments/Updates
  • 6.11 YC Biotech (Jiangsu)
    • 6.11.1 YC Biotech (Jiangsu) Corporation Information
    • 6.11.2 YC Biotech (Jiangsu) Mesalazine Description and Business Overview
    • 6.11.3 YC Biotech (Jiangsu) Mesalazine Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 YC Biotech (Jiangsu) Product Portfolio
    • 6.11.5 YC Biotech (Jiangsu) Recent Developments/Updates
  • 6.12 Xinxiang Tianfeng Fine Chemical
    • 6.12.1 Xinxiang Tianfeng Fine Chemical Corporation Information
    • 6.12.2 Xinxiang Tianfeng Fine Chemical Mesalazine Description and Business Overview
    • 6.12.3 Xinxiang Tianfeng Fine Chemical Mesalazine Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Xinxiang Tianfeng Fine Chemical Product Portfolio
    • 6.12.5 Xinxiang Tianfeng Fine Chemical Recent Developments/Updates

7 Mesalazine Manufacturing Cost Analysis

  • 7.1 Mesalazine Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Mesalazine
  • 7.4 Mesalazine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Mesalazine Distributors List
  • 8.3 Mesalazine Customers

9 Mesalazine Market Dynamics

  • 9.1 Mesalazine Industry Trends
  • 9.2 Mesalazine Growth Drivers
  • 9.3 Mesalazine Market Challenges
  • 9.4 Mesalazine Market Restraints

10 Global Market Forecast

  • 10.1 Mesalazine Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Mesalazine by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Mesalazine by Type (2022-2027)
  • 10.2 Mesalazine Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Mesalazine by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Mesalazine by Application (2022-2027)
  • 10.3 Mesalazine Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Mesalazine by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Mesalazine by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Purity ≥ 97 %
    Purity ≥ 98 %
    Purity ≥ 99 %
    According to the type, purity ≥ 98% is the highest, reaching 48.44% in 2019.

    Segment by Application
    Mesalazine Tablets
    Mesalazine Capsules
    Others
    Mesalazine tablets has the highest market share in terms of application, at 50.61% in 2019.

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E

    By Company
    Syntese A/S
    Divis Laboratories
    Cambrex Corporation
    Ipca Laboratories
    PharmaZell
    Lasa Loboratory
    Erregierre SpA
    Corden Pharma Bergamo
    CTX Lifescience
    Ishita Active Pharma Ingredients
    YC Biotech (Jiangsu)
    Xinxiang Tianfeng Fine Chemical


    Summary:
    Get latest Market Research Reports on Mesalazine. Industry analysis & Market Report on Mesalazine is a syndicated market report, published as Global Mesalazine Market Research Report 2021. It is complete Research Study and Industry Analysis of Mesalazine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,091.93
    3,137.89
    4,183.85
    2,424.80
    3,637.20
    4,849.59
    313,771.30
    470,656.95
    627,542.60
    211,887.92
    317,831.88
    423,775.84
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report